4 December 2020
Our Head of International Operations, Sebastian Taylor, shares how RCPCH Global has been supporting our partners abroad during the COVID-19 pandemic.
3 December 2020
After a successful RCPCH Conference Online 2020, we’re busy planning the 2021 event - and you are invited to get involved. We will be releasing full event details, including dates, over the coming weeks. In the meantime, the Conference Organising Committee is now inviting submissions of papers for ...
27 November 2020
The Epilepsy12 Youth Advocates have been selected as joint winners in the HQIP Audit Heroes Awards 2020 in the Volunteer of the Year Category, recognising their hard work to support improvements in epilepsy care.
Keeping paediatric diabetes on the radar - how our Diabetes Quality Programme is delivering activities during COVID-19
19 November 2020
We’ve made innovative adaptations to keep Paediatric diabetes on the radar during the COVID-19 pandemic to improve care and outcomes.
16 October 2020
Dr Yincent Tse is Lead for Patient Safety and Quality Improvement on the RCPCH Quality Improvement Committee and joint RCPCH/NPPG Medicines Committee. He recently completed his term as Secretary for the British Association for Paediatric Nephrology, and Deputy Head of School for North East and North...
2 October 2020
An interim clinical commissioning policy has been in place across the UK since 3 July 2020, defining routine access to remdesivir in the treatment of COVID-19 in adults and children aged 12 years or older. However, due to increased demand against available supply, clinicians are now asked to apply t...
30 September 2020
Dr Colin Dunkley, Consultant Paediatrician and Clinical Lead for Epilepsy12 tells us about the recent report on the clinical and organisational aspects of epilepsies care for children and young people in England and Wales.
25 September 2020
Two new reports have been released outlining the findings of a snapshot survey of the UK's general paediatric and neonatal services and workforce in September 2019. The reports provide a pre-COVID benchmark and give recommendations to government, service planners and other decision makers about how ...
9 September 2020
Following recent publication of the REMAP-CAP trial for hydrocortisone and a meta-analysis of corticosteroids, the World Health Organization (WHO) has recently issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease.
27 August 2020
Dr Andrea Srur, Programme Manager for the national Diabetes Quality Programme, describes the recent successes from this project and the challenges presented by the COVID-19 outbreak.